GSK PLC GSK shares advanced 1.39% to £13.91 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.85% to 9,138.37. GSK PLC ...

AstraZeneca and GSK shares were among today’s FTSE 100 index beneficiaries as risk appetite surged on the back of Japan’s US trade deal. London’s top flight added another 0.6% to a fresh record of ...

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent seasonal influenza vaccines to US healthcare providers and pharmacies in preparation for the 2025-26 flu season.

Stock performance has followed, with the shares delivering a mind-boggling 300% gain since their market debut three months ago. That's compared with a 12% increase for the S&P 500.

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.

GSK plc (NYSE: GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA approval for a 200 mg/mL autoinjector of Benlysta (belimumab) for the ...

Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug costs, and lost Medicaid rebates.

Time is the secret ingredient of investing, a market veteran says. Over many decades, diversified stock index funds have produced extraordinary results.

The stock performance of BBAI has been tumultuous. It skyrocketed seven-fold from below $1.50 in July of the previous year to over $10 in early 2025 ...